These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 17145568

  • 1. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
    Glueck CJ, Golnik KC, Aregawi D, Goldenberg N, Sieve L, Wang P.
    Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568
    [Abstract] [Full Text] [Related]

  • 2. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 3. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug 01; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 7. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr 01; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 8. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
    Qublan HS, Yannakoula EK, Al-Qudah MA, El-Uri FI.
    Saudi Med J; 2007 Nov 01; 28(11):1694-9. PubMed ID: 17965792
    [Abstract] [Full Text] [Related]

  • 9. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb 01; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 10. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
    Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P.
    Hum Reprod; 2004 Jun 01; 19(6):1323-30. PubMed ID: 15117896
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.
    Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P.
    J Lab Clin Med; 2003 Jul 01; 142(1):35-45. PubMed ID: 12878984
    [Abstract] [Full Text] [Related]

  • 12. Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome.
    Zafar S.
    J Ayub Med Coll Abbottabad; 2005 Jul 01; 17(4):54-6. PubMed ID: 16599037
    [Abstract] [Full Text] [Related]

  • 13. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Kavŭrdzhikova S.
    Akush Ginekol (Sofiia); 2006 Jul 01; 45(6):29-35. PubMed ID: 17168480
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ, Sieve L, Zhu B, Wang P.
    Metabolism; 2006 Mar 01; 55(3):345-52. PubMed ID: 16483878
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF.
    Hum Reprod; 2007 Nov 01; 22(11):2967-73. PubMed ID: 17766923
    [Abstract] [Full Text] [Related]

  • 16. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality.
    Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, Schedlowski M, van Halteren WB, Kimmig R, Janssen OE.
    Hum Reprod; 2006 Jul 01; 21(7):1925-34. PubMed ID: 16549423
    [Abstract] [Full Text] [Related]

  • 17. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Glueck CJ, Pranikoff J, Aregawi D, Wang P.
    Fertil Steril; 2008 Mar 01; 89(3):625-34. PubMed ID: 17678910
    [Abstract] [Full Text] [Related]

  • 18. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Glueck CJ, Bornovali S, Pranikoff J, Goldenberg N, Dharashivkar S, Wang P.
    Diabet Med; 2004 Aug 01; 21(8):829-36. PubMed ID: 15270785
    [Abstract] [Full Text] [Related]

  • 19. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.
    Metabolism; 2007 Jan 01; 56(1):129-34. PubMed ID: 17161235
    [Abstract] [Full Text] [Related]

  • 20. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.
    Gynecol Endocrinol; 2007 Mar 01; 23(3):146-52. PubMed ID: 17454168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.